Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Cs Genetics Limited maintains 2 pending office actions distributed across the Biotechnology & Pharmaceuticals technology area. The portfolio is currently being reviewed by 2 distinct examiners operating within multiple art units. This distribution indicates that the company's active patent applications are facing different examination environments despite being within the same technology sector. A decentralized approach like this requires the applicant to manage varied examiner perspectives simultaneously.
KAUP, SAHANA S serves as the busiest examiner for the portfolio with 1 pending office action under review. This represents 1 of the total active matters currently pending for the company. With the workload split between multiple officials, the prosecution outcomes are subject to the individual interpretations of different patent officials in the Biotechnology & Pharmaceuticals area. Understanding the specific tendencies of each assigned examiner is essential for maintaining consistency across the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAUP, SAHANA S | 1 | 44.5% | +29.7% |
| HAVLIN, ROBERT H | 1 | 51.3% | +28.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17591930 | REAGENTS, KITS AND METHODS FOR MOLECULAR BARCODING | HAVLIN, ROBERT H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17839272 | Methods and Reagents for Molecular Barcoding | KAUP, SAHANA S | 147d overdue |
| 17591930 | REAGENTS, KITS AND METHODS FOR MOLECULAR BARCODING | HAVLIN, ROBERT H | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17839272 | Methods and Reagents for Molecular Barcoding | KAUP, SAHANA S | 1612 | §103Other | Non-Final OA | 147d overdue | Pending | Jun 13, 2022 |
| 17591930 | REAGENTS, KITS AND METHODS FOR MOLECULAR BARCODING | HAVLIN, ROBERT H | 1626 | §102§103Other | Non-Final OA | — | Pending | Feb 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCs Genetics Limited has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Sahana S Kaup has the most, with 1 of Cs Genetics Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
